浮出水面

China's pharmaceutical industry sees accelerated innovation breakthroughs in H1_我的网站

父女七日变

一 | 记者从日前召开的省委省政府法律顾问聘任大会上了解到，截至目前，全省已建立以党内法规工作机构、政府法制机构人员为主体，外聘法学专家和律师为补充的5860人的党政机关法律顾问队伍，基本实现了省市县三级政府法律顾问全覆盖。 (ECNS) -- China's pharmaceutical industry accelerated innovation in the first half of this year, with domestic companies steadily improving their R&D capabilities and growth momentum continuing to strengthen, data showed. China's first broad-spectrum targeted anticancer drug entered clinical use at major hospitals across the country this year. It took only eight months to go from submission to market approval. A total of 38 innovative drugs were approved for marketing in China in the first half, of which 31 were developed domestically, more than 80% of the total. Eleven drugs featuring new targets or new mechanisms were all developed independently by domestic companies, producing a number of world-first innovations. By the end of 2025, China had 4,751 innovative drugs under development, one-third of the global total and the largest pipeline of any country. Behind this concentration of results lies a steadily strengthening industrial base. China has a complete pharmaceutical supply chain. It is not only the world's largest producer of active pharmaceutical ingredients but has also built a production system covering every pharmaceutical category. This year, digital, intelligent, and green technologies have driven the industry's transformation and upgrading. At a biopharmaceutical company in Shanxi Province, a newly built AI-powered bio-computing center can identify the structures of millions of protein functional domains in a short time, screening out ineffective molecules directly. To date, China has supported 21 pharmaceutical firms in building excellent-level smart factories and has cultivated more than 300 green factories. In the first half, the added value of pharmaceutical enterprises above the designated scale grew 6.4% year on year, and exports held strong. The world's first chemotherapy-sparing drug for gastric cancer, launched this year, had already earned overseas revenue through licensing deals before it reached the market, and is now exported to multiple countries and regions. In the first half, the total value of China's innovative drug out-licensing deals reached $110 billion, the industry's export delivery value grew 9% year on year, and high-value-added products made up nearly 20% of the total. (By Tang Yuxian) 。今年上半年，全省法律顾问参与省（市）政府重大行政决策2738件，同比增长37.8%，在推动法治辽宁建设中凸显积极作用。　　我省于2017年出台建立政府法律顾问工作制度的文件，明确规定政府法律顾问队伍组成、工作职责等制度要素内容，夯实了制度基础。全省把切实加强政府法律顾问工作作为推进依法治省和法治政府建设的重要内容来抓，各市积极探索符合本地实际的方法路径，选优配强内部政府法律顾问工作人员，完善外聘政府法律顾问考核评价机制，聚焦地方立法、行政决策、合同订立、行政应诉、行政调解等环节，推动法律顾问从法律风险的“善后者”向“防控者”转变。　　为更好发挥法律顾问“智囊”作用，我省在加强高质量法治人才储备，建立党政机关法律顾问人才库基础上，通过制定有力举措，推动法律顾问制度向乡镇延伸，力争在2025年年底前实现省市县乡四级法律顾问全覆盖。同时，建立以工作质效为导向的监督管理模式，围绕各地区的攻坚任务成立专门法律顾问团队，以精准化的法律服务为“八大攻坚”重点任务提供有力法治保障。责任编辑：李丹。